1 Min Read
June 15 (Reuters) - INNATE PHARMA SA:
* REG-INNATE PHARMA : DOSE-ESCALATION DATA SHOW FAVORABLE SAFETY PROFILE AND PROMISING CLINICAL ACTIVITY FOR IPH4102 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.